ABN Amro Investment Solutions Cuts Holdings in Danaher Corporation $DHR

ABN Amro Investment Solutions trimmed its holdings in shares of Danaher Corporation (NYSE:DHR) by 15.4% during the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 384,296 shares of the conglomerate’s stock after selling 70,025 shares during the quarter. Danaher accounts for approximately 1.3% of ABN Amro Investment Solutions’ holdings, making the stock its 11th biggest holding. ABN Amro Investment Solutions’ holdings in Danaher were worth $87,973,000 at the end of the most recent quarter.

Several other institutional investors also recently bought and sold shares of the business. Enterprise Financial Services Corp increased its holdings in Danaher by 1.4% during the fourth quarter. Enterprise Financial Services Corp now owns 3,219 shares of the conglomerate’s stock valued at $737,000 after buying an additional 46 shares during the period. Kennebec Savings Bank increased its holdings in Danaher by 1.4% during the fourth quarter. Kennebec Savings Bank now owns 3,348 shares of the conglomerate’s stock valued at $766,000 after buying an additional 46 shares during the period. Revolve Wealth Partners LLC increased its holdings in Danaher by 2.6% during the fourth quarter. Revolve Wealth Partners LLC now owns 1,870 shares of the conglomerate’s stock valued at $428,000 after buying an additional 47 shares during the period. High Note Wealth LLC boosted its stake in Danaher by 19.2% in the fourth quarter. High Note Wealth LLC now owns 292 shares of the conglomerate’s stock valued at $67,000 after acquiring an additional 47 shares in the last quarter. Finally, Kestra Private Wealth Services LLC boosted its stake in Danaher by 0.3% in the third quarter. Kestra Private Wealth Services LLC now owns 15,421 shares of the conglomerate’s stock valued at $3,057,000 after acquiring an additional 48 shares in the last quarter. 79.05% of the stock is owned by hedge funds and other institutional investors.

Danaher Trading Up 2.5%

NYSE:DHR opened at $171.19 on Thursday. Danaher Corporation has a 12 month low of $160.93 and a 12 month high of $242.80. The firm has a fifty day simple moving average of $184.41 and a 200-day simple moving average of $209.29. The company has a current ratio of 1.87, a quick ratio of 1.52 and a debt-to-equity ratio of 0.33. The company has a market capitalization of $121.16 billion, a P/E ratio of 33.11, a PEG ratio of 2.23 and a beta of 0.81.

Danaher (NYSE:DHR) last posted its quarterly earnings data on Monday, April 20th. The conglomerate reported $2.06 EPS for the quarter, topping the consensus estimate of $1.94 by $0.12. Danaher had a net margin of 14.89% and a return on equity of 10.91%. The business had revenue of $5.95 billion during the quarter, compared to the consensus estimate of $6 billion. During the same period in the previous year, the firm posted $1.88 earnings per share. The business’s revenue for the quarter was up 3.7% compared to the same quarter last year. On average, equities research analysts anticipate that Danaher Corporation will post 8.43 earnings per share for the current year.

Danaher Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, July 31st. Stockholders of record on Friday, June 26th will be paid a dividend of $0.40 per share. This represents a $1.60 annualized dividend and a dividend yield of 0.9%. The ex-dividend date is Friday, June 26th. Danaher’s payout ratio is presently 30.95%.

Wall Street Analysts Forecast Growth

Several equities research analysts have weighed in on the stock. Wells Fargo & Company lowered their target price on shares of Danaher from $240.00 to $212.00 and set an “equal weight” rating for the company in a research note on Wednesday, April 22nd. Morgan Stanley lowered their target price on shares of Danaher from $270.00 to $255.00 and set an “overweight” rating for the company in a research note on Wednesday, April 22nd. UBS Group lowered their target price on shares of Danaher from $270.00 to $250.00 and set a “buy” rating for the company in a research note on Wednesday, April 22nd. Deutsche Bank Aktiengesellschaft restated a “buy” rating on shares of Danaher in a research note on Thursday, January 29th. Finally, Rothschild & Co Redburn set a $205.00 target price on shares of Danaher in a research note on Friday, April 17th. Nineteen analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $238.65.

Danaher Company Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.